Company: REVB
Filing Date: 2025-03-06
Form Type: 10-K
Source: 0000950170-25-034584
Chunk: 236

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-03-06
Form: 10-K
Item: Item 1B
Chunk 236
---
 

        Volatility

        47
        %

        Expected term (years)

        5

        Risk-free interest rate

        1.54
        %

        Expected dividend yield

        0.0
        %
       
      Class B Common Stock WarrantsIn connection with closing of a public offering on July 28, 2022 (“the July 2022 Public Offering”), the Company issued and has outstanding 8,333,334 warrants to purchase an aggregate of 497 shares of common stock at an exercise price of $10,080.00 per share (the “Class B Common Stock Warrants”), valued on the public offering purchase date in the aggregate at $4.5 million and included in the issuance costs of the public offering and treated as equity. The warrants were exercisable immediately upon issuance, provide for a cash or cashless exercise right and expire on July 28, 2027.The fair value of the Class B Common Stock Warrants were estimated using the Black-Scholes option pricing model with the following assumptions: 

        Volatility

        144
        %

        Expected term (years)

        5

        Risk-free interest rate

        2.69
        %

        Expected dividend yield

        0.0
        %
       
      Class B Placement Agent Common Stock WarrantsIn connection with the July 2022 Public Offering, the Company issued warrants to the Placement Agent to purchase up to 35 shares of common stock at an exercise price of $12,600.00 per share (the “Class B Placement Agent Common Stock Warrants”), valued on the public offering purchase date in the aggregate at $0.3 million and included in the issuance costs of the public offering and treated as equity. The warrants were exercisable immediately upon issuance, provide for a cash or cashless exercise right and expire on July 25, 2027.The fair value of the Class B Placement Agent Common Stock Warrants were estimated using the Black-Scholes option pricing model with the following assumptions:  

        Volatility

        144
        %

        Expected term (years)

        5

        Risk-free interest rate

        2.69
        %

        Expected dividend yield

        0.0
        %
       
      Class C Pre-Funded WarrantsIn connection with the February 2023 Public Offering, the Company issued pre-funded warrants to purchase up to 699 shares of common stock at an exercise price of $0.048 per share